{
    "title": "Lilly gives no time frame on arthritis drug delay; shares fall",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4443238/Eli-Lillys-profit-beats-demand-newer-drugs.html",
    "date": "2017-04-25",
    "keywords": [
        "approval",
        "drug",
        "baricitinib",
        "year",
        "percent",
        "cancer",
        "bill",
        "information",
        "profit",
        "analyst",
        "medicine",
        "fda",
        "revenue",
        "share",
        "quarter",
        "trulicity",
        "tuesday",
        "arthritis",
        "surprise",
        "rejection",
        "food",
        "administration",
        "month",
        "drugmaker",
        "upside",
        "credit",
        "suisse",
        "vamil",
        "divan",
        "clarity",
        "assessment",
        "agency",
        "conference",
        "call",
        "letter",
        "estimate",
        "head",
        "dosing",
        "safety",
        "corp",
        "confidence",
        "goal",
        "growth",
        "thomson",
        "tony",
        "butler",
        "health",
        "acquisition",
        "look",
        "dont",
        "stock",
        "blockbuster",
        "victoza",
        "street",
        "forecast",
        "line",
        "taltz",
        "psoriasis",
        "company",
        "cyramza",
        "immunooncology",
        "lung",
        "berkrot",
        "york",
        "banerjee",
        "bengaluru",
        "editing"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}